HOME >> BIOLOGY >> NEWS
Synthetic peptide targets latent papilloma virus infections

Berkeley -- While a newly marketed vaccine promises to drastically reduce human papilloma virus (HPV) infections, the major cause of cervical cancer, a new discovery by University of California, Berkeley, researchers could some day help the millions of people already infected and at constant risk of genital warts and cancer.

One study found that 75 percent of sexually active men and women under 50 have, or have had, an HPV infection, while 10,000 women annually develop cervical cancer, more than 90 percent of which is caused by HPV. Four thousand women die of cervical cancer each year.

Once infected, it's difficult to rid oneself of the virus because it hides as a latent DNA in cells of the epithelial tissue, such as skin and the lining of the vagina and cervix, and spreads as these cells divide.

The UC Berkeley team created a protein fragment, or peptide, that successfully prevents the virus from hitching a ride on a cell's chromosomes as the cell divides. If such a peptide - or more likely, a drug that mimics the action of the peptide - works in the body, it would effectively stop the virus from spreading or generating warts, which can progress to cancer.

"We're optimistic that this will work generally for many different genetic variants of human papilloma virus, though it's too early to say how many of the genotypes of this virus will respond," said Michael Botchan, professor of molecular and cell biology and a faculty affiliate of the UC Berkeley branch of the California Institute for Quantitative Biology (QB3). "The hope is to have one drug that works for all different human virus types."

"The second most preventable cancer in the world, after lung cancer, is cervical cancer, the result of high HPV infection rates in the developing world, in Asia and South America and Africa," he added. "If we can get something to stop HPV replication, it would have a big health impact."

Botchan, post-doctoral fellow Eric
'"/>

Contact: Robert Sanders
rsanders@berkeley.edu
510-643-6998
University of California - Berkeley
2-Jan-2007


Page: 1 2 3 4

Related biology news :

1. Synthetic adhesive mimics sticking powers of gecko and mussel
2. Springer to publish new journal Systems and Synthetic Biology
3. Synthetic molecule causes cancer cells to self-destruct
4. New designer lipid-like peptide with lipid nanostructures for drug delivery systems
5. New NIST reference material for peptide analysis
6. UCLA AIDS Institute researchers find a peptide that encourages HIV infection
7. Therapeutic peptide frees the protein p73 to kill tumor cells
8. Scientists identify 36 genes, 100 neuropeptides in honey bee brains
9. Defense peptide found in primates may block some human HIV transmissions
10. Patent awarded for LSUHSC-developed peptide that blocks lethal toxins of anthrax
11. Targeted drug delivery now possible with pHLIP peptide

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/12/2019)... Calif. (PRWEB) , ... March 12, 2019 , ... ... in strong multi-factor authentication and combined technology all-in-one smart cards, announced today the ... FIDO strong authentication: the Fingerprint Biometric and Dynamic CVV Payment cards. These advanced ...
(Date:3/9/2019)... ... March 07, 2019 , ... ... and cellular stress research tools today announced the publication of its recent ... treatment. The antibody, still at a pre-clinical stage of development, moves the company ...
(Date:3/1/2019)... ... March 01, 2019 , ... Geneious would like to announce it is ... to Vector NTI. , Geneious Prime already has a dedicated importer for Vector ... so that files will be organised in Geneious in the same way. The ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... (PRWEB) , ... March 13, 2019 , ... Murrieta ... The Board will bring industry specific and broader business experience to bear as genomic ... to have access to the knowledge and expertise that our Advisory Board brings to ...
(Date:3/11/2019)... ... March 11, 2019 , ... In this live webinar, the featured ... clinical trial efficiency and experience. Participants will learn how to use the information they ... ensure that the simple or complex randomization scheme is properly designed and set up ...
(Date:3/5/2019)... , ... March 05, 2019 , ... ... cold chain engineering firm with regulatory filing authorities, logistics network experts, and experienced ... to initiate its participation in the Inc. Verified Profile program, Inc. editors independently ...
(Date:2/22/2019)... ... February 20, 2019 , ... Murrieta Genomics , the ... rapidly growing NGS (Next Generation Sequencing) field, have announced a partnership to bring ... "As an innovation center and idea incubator, we are always looking for new ...
Breaking Biology Technology:
Cached News: